Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,0.93 [0.9-0.96],1.21526677420163e-05,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,10,0.94 [0.91-0.97],1.98281070956382e-05,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,17,0.94 [0.91-0.97],5.35471612460556e-05,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,JAM2,Junctional adhesion molecule B,Inverse variance weighted,2,0.72 [0.61-0.85],0.000111434794467438,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PENK,Proenkephalin-A,Inverse variance weighted,19,1.06 [1.03-1.09],0.000236884456765771,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,0.91 [0.86-0.96],0.000280814071367227,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,19,1.06 [1.03-1.09],0.000287912894875715,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,NUCB2,Nucleobindin-2,Inverse variance weighted,24,1.05 [1.02-1.07],0.000376973007323008,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SERPINA3,Alpha-1-antichymotrypsin,Inverse variance weighted,10,0.95 [0.93-0.98],0.00102086673250438,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,XCL1,Lymphotactin,Inverse variance weighted,31,0.97 [0.96-0.99],0.0011072937839379,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,33,1.03 [1.01-1.05],0.00130914363217893,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,0.97 [0.94-0.99],0.00144152012751365,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MDK,Midkine,Inverse variance weighted,4,1.12 [1.04-1.2],0.00154256905716865,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,19,0.98 [0.96-0.99],0.0030910812035533,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,49,0.99 [0.98-1],0.00507125680669124,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,RSPO3,R-spondin-3,Inverse variance weighted,6,0.92 [0.87-0.98],0.00546074610530405,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,1.09 [1.02-1.16],0.00747463349461807,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,0.98 [0.96-0.99],0.00930637393131882,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,28,1.04 [1.01-1.06],0.010061059464429,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD302,CD302 antigen,Inverse variance weighted,9,0.94 [0.9-0.99],0.0102188003872789,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TCTN3,Tectonic-3,Inverse variance weighted,33,1.03 [1.01-1.05],0.0105333619221013,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,28,1.02 [1-1.04],0.01075732394216,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,BSG,Basigin,Wald ratio,1,1.11 [1.02-1.2],0.0116743662410543,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,0.73 [0.57-0.94],0.0163705464115225,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,5,0.92 [0.87-0.99],0.016549104605091,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,0.96 [0.92-0.99],0.0177144612568082,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,21,1.02 [1-1.04],0.0190219318115595,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TCN2,Transcobalamin-2,Inverse variance weighted,34,0.98 [0.96-1],0.0198644433304201,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD276,CD276 antigen,Inverse variance weighted,20,0.98 [0.96-1],0.0223234931768737,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,1.09 [1.01-1.17],0.0245973393667098,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,0.87 [0.78-0.98],0.0248967767174775,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,16,0.96 [0.94-1],0.0254347173251548,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,1.05 [1.01-1.09],0.0268290732172852,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GLO1,Lactoylglutathione lyase,Inverse variance weighted,13,1.04 [1-1.07],0.0303855710816562,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,44,0.98 [0.97-1],0.0311607263274014,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,10,1.04 [1-1.08],0.0342364620673597,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,0.99 [0.98-1],0.03449282662771,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,HIP1R,Huntingtin-interacting protein 1-related protein,Wald ratio,1,0.88 [0.78-0.99],0.0355503693237297,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,0.98 [0.95-1],0.0355511077943709,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,1.04 [1-1.09],0.0380596563623826,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,BCAN,Brevican core protein,Inverse variance weighted,3,0.95 [0.91-1],0.0383781604941551,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,Inverse variance weighted,34,0.99 [0.97-1],0.0400961890150922,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,1.08 [1-1.16],0.0401680843540987,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,7,0.95 [0.91-1],0.0404688069637247,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CNDP1,Beta-Ala-His dipeptidase,Inverse variance weighted,20,1.03 [1-1.05],0.0425248086413832,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,7,1.06 [1-1.12],0.0431435844420613,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,COLEC12,Collectin-12,Inverse variance weighted,11,1.06 [1-1.12],0.0452709506753651,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CST3,Cystatin-C,Inverse variance weighted,10,1.03 [1-1.07],0.0460236998074474,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,0.96 [0.92-1],0.0460770212052652,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,1.04 [1-1.08],0.0468903252626993,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,16,0.97 [0.95-1],0.0485695957948189,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,1.14 [1-1.29],0.0485699901650175,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,8,0.96 [0.93-1],0.0520879828119143,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,KITLG,Kit ligand,Wald ratio,1,0.81 [0.66-1],0.0527436786528253,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ADGRD1,Adhesion G-protein coupled receptor D1,Inverse variance weighted,22,1.02 [1-1.04],0.0539892303595293,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,1.04 [1-1.08],0.0547423232182992,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MSMB,Beta-microseminoprotein,Inverse variance weighted,64,1.01 [1-1.03],0.0551673444597547,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GRN,Progranulin,Inverse variance weighted,7,1.03 [1-1.07],0.0571858500270997,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,HYAL1,Hyaluronidase-1,Inverse variance weighted,5,1.05 [1-1.11],0.0592037777013262,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,7,1.03 [1-1.06],0.0604663190186407,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,4,1.04 [1-1.07],0.0648665065271644,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,Inverse variance weighted,6,1.07 [1-1.16],0.0671066284629976,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,HNMT,Histamine N-methyltransferase,Inverse variance weighted,27,1.02 [1-1.04],0.0680197627614127,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,5,0.95 [0.9-1],0.0689909924411551,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CDH3,Cadherin-3,Inverse variance weighted,2,1.12 [0.99-1.27],0.0697198819355071,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IL19,Interleukin-19,Inverse variance weighted,11,0.96 [0.92-1],0.072415738284424,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IGFBP1,Insulin-like growth factor-binding protein 1,Wald ratio,1,1.25 [0.98-1.58],0.072554324262813,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,1.1 [0.99-1.21],0.0757586716787334,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,2,0.93 [0.85-1.01],0.0774327260084031,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SEMA3F,Semaphorin-3F,Inverse variance weighted,15,1.06 [0.99-1.13],0.0815179245854821,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LMOD1,Leiomodin-1,Inverse variance weighted,5,1.08 [0.99-1.19],0.0868141016542897,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,22,0.98 [0.96-1],0.0886254899316882,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,2,1.07 [0.99-1.16],0.0895796569712996,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,DPP10,Inactive dipeptidyl peptidase 10,Inverse variance weighted,13,1.04 [0.99-1.08],0.089580420466342,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ALPP,"Alkaline phosphatase, placental type",Inverse variance weighted,31,0.99 [0.97-1],0.0908661704866026,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,9,0.97 [0.94-1],0.091679804455543,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PRSS2,Trypsin-2,Inverse variance weighted,3,1.09 [0.99-1.19],0.0972572208519547,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CCL21,C-C motif chemokine 21,Inverse variance weighted,4,0.93 [0.86-1.01],0.100384058023534,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SUSD2,Sushi domain-containing protein 2,Inverse variance weighted,16,0.99 [0.97-1],0.100430194417568,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,0.99 [0.97-1],0.103656982868806,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,5,0.96 [0.91-1.01],0.105142659200209,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FCRLB,Fc receptor-like B,Inverse variance weighted,61,0.99 [0.98-1],0.105344898272653,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,0.96 [0.92-1.01],0.105512089559408,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,COL9A1,Collagen alpha-1(IX) chain,Inverse variance weighted,8,1.03 [0.99-1.07],0.107456141737921,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,1.04 [0.99-1.09],0.107659124272919,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FSTL1,Follistatin-related protein 1,Inverse variance weighted,3,1.06 [0.99-1.13],0.108116686165848,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CBLN4,Cerebellin-4,Inverse variance weighted,11,1.03 [0.99-1.08],0.108385843656309,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LUZP2,Leucine zipper protein 2,Inverse variance weighted,8,1.04 [0.99-1.08],0.114767871813456,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TFF1,Trefoil factor 1,Inverse variance weighted,8,0.97 [0.93-1.01],0.11804076787153,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.9 [0.79-1.03],0.119693946339173,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,DNER,Delta and Notch-like epidermal growth factor-related receptor,Inverse variance weighted,12,1.02 [0.99-1.05],0.120101955863415,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MMP7,Matrilysin,Inverse variance weighted,13,1.03 [0.99-1.07],0.121354042973881,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,32,1.01 [1-1.03],0.124150190360608,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GFAP,Glial fibrillary acidic protein,Inverse variance weighted,4,0.93 [0.84-1.02],0.128082527612637,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,OSM,Oncostatin-M,Wald ratio,1,0.89 [0.76-1.04],0.128804683945185,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,30,0.99 [0.97-1],0.129240128510967,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,1.09 [0.97-1.23],0.130929442155216,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,0.95 [0.88-1.02],0.131116622583222,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,0.84 [0.66-1.05],0.13114244639888,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Inverse variance weighted,30,0.98 [0.96-1.01],0.131513257737659,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,12,1.04 [0.99-1.1],0.132176981021101,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,RNASE4,Ribonuclease 4,Inverse variance weighted,11,0.98 [0.95-1.01],0.133429850366866,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,Inverse variance weighted,3,0.94 [0.86-1.02],0.13524555248736,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CCL18,C-C motif chemokine 18,Inverse variance weighted,15,0.98 [0.96-1.01],0.13681778785331,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PDCD1,Programmed cell death protein 1,Inverse variance weighted,9,0.95 [0.89-1.02],0.141505395970591,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,1.05 [0.98-1.12],0.144112999157403,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TMPRSS11D,Transmembrane protease serine 11D,Inverse variance weighted,3,1.06 [0.98-1.15],0.14427875474853,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PRSS8,Prostasin,Inverse variance weighted,5,0.95 [0.88-1.02],0.145402014557408,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,7,1.05 [0.98-1.12],0.149410113907968,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MMP8,Neutrophil collagenase,Inverse variance weighted,17,0.98 [0.95-1.01],0.153014053100951,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GSN,Gelsolin,Inverse variance weighted,5,0.94 [0.86-1.02],0.155015163203749,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,3,0.94 [0.87-1.02],0.160141421481671,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ITGA11,Integrin alpha-11,Inverse variance weighted,8,1.03 [0.99-1.06],0.163351863855169,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,8,1.04 [0.98-1.1],0.166831328509777,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD300A,CMRF35-like molecule 8,Inverse variance weighted,5,1.03 [0.99-1.07],0.17183947095306,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CFH,Complement factor H,Inverse variance weighted,19,0.97 [0.93-1.01],0.172501864890654,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,0.94 [0.86-1.03],0.173331665903191,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,1.03 [0.99-1.08],0.174249189629167,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GPRC5C,G-protein coupled receptor family C group 5 member C,Wald ratio,1,0.94 [0.85-1.03],0.174738909248187,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,13,1.03 [0.99-1.07],0.177203485701607,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,NPPC,C-type natriuretic peptide,Wald ratio,1,0.84 [0.65-1.08],0.17860230388304,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,4,1.03 [0.99-1.07],0.178732595725153,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD34,Hematopoietic progenitor cell antigen CD34,Wald ratio,1,1.13 [0.94-1.36],0.17905410802516,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,0.98 [0.96-1.01],0.181407416386842,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PALM,Paralemmin-1,Inverse variance weighted,6,0.96 [0.91-1.02],0.182271547703371,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,6,0.98 [0.95-1.01],0.184227152327315,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,HMOX2,Heme oxygenase 2,Inverse variance weighted,2,0.89 [0.75-1.06],0.185308998549317,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,DSC2,Desmocollin-2,Inverse variance weighted,9,0.98 [0.94-1.01],0.18598440935532,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PLA2G2A,"Phospholipase A2, membrane associated",Inverse variance weighted,19,1.01 [0.99-1.03],0.186592432622694,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,Inverse variance weighted,26,0.99 [0.97-1.01],0.188234986623257,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CLEC3B,Tetranectin,Inverse variance weighted,7,1.03 [0.98-1.08],0.188727098387425,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SELENOP,Selenoprotein P,Inverse variance weighted,2,1.08 [0.96-1.2],0.19150057911842,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,22,1.02 [0.99-1.05],0.196936108766552,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FAM3C,Protein FAM3C,Inverse variance weighted,2,1.18 [0.92-1.53],0.197549257524755,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,2,1.03 [0.98-1.08],0.200337954577126,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,DRAXIN,Draxin,Inverse variance weighted,13,0.99 [0.96-1.01],0.200946152348652,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,APOA2,Apolipoprotein A-II,Wald ratio,1,0.9 [0.76-1.06],0.201849080410436,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,NECTIN4,Nectin-4,Inverse variance weighted,7,1.03 [0.99-1.07],0.202412873761347,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Wald ratio,1,0.94 [0.86-1.03],0.202736535083267,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,Wald ratio,1,0.94 [0.85-1.03],0.202736535083268,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CCL16,C-C motif chemokine 16,Inverse variance weighted,19,1.01 [0.99-1.02],0.205914836838486,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,RETN,Resistin,Inverse variance weighted,9,1.02 [0.99-1.05],0.205994359861476,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PTN,Pleiotrophin,Inverse variance weighted,4,1.06 [0.97-1.16],0.20910773617352,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CPM,Carboxypeptidase M,Inverse variance weighted,4,1.04 [0.98-1.11],0.209601065328791,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MFGE8,Lactadherin,Inverse variance weighted,11,0.98 [0.94-1.01],0.211807069420127,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,17,0.98 [0.95-1.01],0.213056374248574,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MMP12,Macrophage metalloelastase,Inverse variance weighted,18,0.99 [0.97-1.01],0.215756064419227,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,OGN,Mimecan,Inverse variance weighted,30,0.99 [0.96-1.01],0.216663999389378,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Wald ratio,1,1.06 [0.96-1.17],0.220853937971539,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.12 [0.93-1.33],0.226140505513704,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SOD2,"Superoxide dismutase [Mn], mitochondrial",Inverse variance weighted,2,0.96 [0.89-1.03],0.227423519211896,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,1.04 [0.97-1.12],0.230118956842537,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,44,1.01 [0.99-1.04],0.231822793901305,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SCGB3A2,Secretoglobin family 3A member 2,Inverse variance weighted,5,0.97 [0.94-1.02],0.232360032272791,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ITGB2,Integrin beta-2,Inverse variance weighted,4,0.96 [0.91-1.02],0.233086284638359,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IGFBP3,Insulin-like growth factor-binding protein 3,Inverse variance weighted,30,1.01 [0.99-1.04],0.235274415315095,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.06 [0.96-1.17],0.235725794754932,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,3,1.04 [0.98-1.1],0.236816943397531,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,1.04 [0.97-1.12],0.237580554731543,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CCN3,CCN family member 3,Inverse variance weighted,19,1.03 [0.98-1.07],0.239404858647622,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MXRA8,Matrix remodeling-associated protein 8,Wald ratio,1,0.92 [0.79-1.06],0.240124640575531,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MME,Neprilysin,Inverse variance weighted,3,0.92 [0.81-1.05],0.242728846125247,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,3,0.97 [0.91-1.02],0.244977069887924,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SERPINB8,Serpin B8,Inverse variance weighted,28,1.01 [0.99-1.02],0.245227202991051,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,11,1.02 [0.98-1.06],0.252021348309841,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GUCA2A,Guanylin,Inverse variance weighted,9,1.03 [0.98-1.08],0.25545391733938,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,12,1.01 [0.99-1.04],0.258341913567919,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Wald ratio,1,0.9 [0.76-1.08],0.258739436894771,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PI3,Elafin,Inverse variance weighted,10,0.98 [0.93-1.02],0.259555383387342,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CALCA,Calcitonin,Inverse variance weighted,5,0.95 [0.88-1.04],0.266062376893555,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ALCAM,CD166 antigen,Inverse variance weighted,6,0.96 [0.9-1.03],0.266108409968849,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,2,1.04 [0.97-1.1],0.271213460074461,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PYY,Peptide YY,Inverse variance weighted,6,0.97 [0.92-1.02],0.271850600325547,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,0.98 [0.96-1.01],0.273139005671983,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,0.99 [0.97-1.01],0.274071707562208,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FGF5,Fibroblast growth factor 5,Inverse variance weighted,36,1.01 [0.99-1.03],0.275110737343803,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,8,0.98 [0.94-1.02],0.275476926234306,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,EGFR,Epidermal growth factor receptor,Inverse variance weighted,7,1.06 [0.95-1.19],0.275609962312938,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,0.97 [0.92-1.02],0.275984660202279,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,AGXT,Serine--pyruvate aminotransferase,Inverse variance weighted,10,0.98 [0.94-1.02],0.277830128729744,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,4,0.95 [0.87-1.04],0.280009742274967,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PVR,Poliovirus receptor,Inverse variance weighted,27,1.01 [0.99-1.04],0.280283778897872,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IL17C,Interleukin-17C,Inverse variance weighted,3,1.06 [0.95-1.17],0.281964985199366,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ORM1,Alpha-1-acid glycoprotein 1,Inverse variance weighted,17,0.98 [0.96-1.01],0.283085427494493,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SHISA5,Protein shisa-5,Inverse variance weighted,5,0.94 [0.85-1.05],0.289435490408479,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FAM3D,Protein FAM3D,Inverse variance weighted,17,0.98 [0.94-1.02],0.290094645446552,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,1.03 [0.97-1.09],0.29179698467821,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,13,0.99 [0.96-1.01],0.291856860731657,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,0.99 [0.96-1.01],0.295659485564209,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,26,1.02 [0.98-1.05],0.298670092788383,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SCGB1A1,Uteroglobin,Inverse variance weighted,12,0.98 [0.95-1.02],0.298961981352338,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,STC1,Stanniocalcin-1,Inverse variance weighted,2,0.92 [0.78-1.08],0.30017069284172,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,10,1.02 [0.98-1.07],0.300358591498511,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,INHBB,Inhibin beta B chain,Inverse variance weighted,10,0.99 [0.96-1.01],0.300486160274228,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SPON1,Spondin-1,Inverse variance weighted,21,0.99 [0.96-1.01],0.303640732313807,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,EFNA1,Ephrin-A1,Inverse variance weighted,11,0.98 [0.95-1.01],0.304295262994932,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,28,1.01 [0.99-1.03],0.306154200510195,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,46,1.01 [0.99-1.02],0.315586673529881,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,1.02 [0.98-1.05],0.318879259542948,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,8,0.98 [0.93-1.02],0.325017809024397,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,12,1.02 [0.98-1.05],0.327958992401981,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,3,0.93 [0.8-1.08],0.328676986457873,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CCL5,C-C motif chemokine 5,Inverse variance weighted,2,1.04 [0.96-1.14],0.329797335668626,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,1.03 [0.97-1.08],0.332102025429867,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TSPAN8,Tetraspanin-8,Inverse variance weighted,25,0.99 [0.96-1.01],0.335758475522409,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,8,1.02 [0.98-1.06],0.33687761119469,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ANXA10,Annexin A10,Wald ratio,1,1.11 [0.9-1.37],0.346213218310182,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD300C,CMRF35-like molecule 6,Inverse variance weighted,12,1.01 [0.99-1.03],0.347661440029544,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,8,0.97 [0.91-1.03],0.35060365711143,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,12,0.99 [0.96-1.02],0.351020985206814,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FCN1,Ficolin-1,Inverse variance weighted,28,1.01 [0.99-1.04],0.352218759495443,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,KLK8,Kallikrein-8,Inverse variance weighted,12,1.01 [0.98-1.05],0.35367616305003,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CCL23,C-C motif chemokine 23,Inverse variance weighted,17,1.01 [0.99-1.03],0.358537602225077,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,6,0.98 [0.95-1.02],0.359234755384178,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,14,0.99 [0.96-1.01],0.359314742920399,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CSTB,Cystatin-B,Inverse variance weighted,28,1.01 [0.99-1.03],0.361385413165239,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,Inverse variance weighted,19,0.99 [0.96-1.01],0.362478980662291,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD7,T-cell antigen CD7,Inverse variance weighted,8,0.99 [0.96-1.01],0.362871092212222,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,27,1.01 [0.99-1.04],0.364717430337749,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,41,0.99 [0.98-1.01],0.367370389058336,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,Inverse variance weighted,15,1.01 [0.98-1.04],0.36742561892823,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SERPING1,Plasma protease C1 inhibitor,Inverse variance weighted,9,0.98 [0.94-1.02],0.370426204039905,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,THBS2,Thrombospondin-2,Inverse variance weighted,16,1.01 [0.99-1.04],0.370957511913191,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LGALS3BP,Galectin-3-binding protein,Inverse variance weighted,4,0.96 [0.88-1.05],0.373242158888656,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PRND,Prion-like protein doppel,Inverse variance weighted,9,0.99 [0.96-1.02],0.375466860285884,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TMSB10,Thymosin beta-10,Wald ratio,1,0.92 [0.77-1.11],0.376600900901465,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FAM3B,Protein FAM3B,Inverse variance weighted,18,1.01 [0.99-1.03],0.378386379003412,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PLIN3,Perilipin-3,Wald ratio,1,0.94 [0.81-1.09],0.382123250977683,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,RSPO1,R-spondin-1,Inverse variance weighted,5,0.98 [0.94-1.03],0.385254789765896,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD83,CD83 antigen,Inverse variance weighted,5,1.04 [0.96-1.12],0.385495630931379,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,3,1.04 [0.96-1.12],0.389774811285192,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,RNASET2,Ribonuclease T2,Inverse variance weighted,14,1.01 [0.98-1.04],0.394692657010173,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,24,0.99 [0.98-1.01],0.394757160866936,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CCL17,C-C motif chemokine 17,Inverse variance weighted,9,0.98 [0.94-1.02],0.395569229768117,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FUOM,Fucose mutarotase,Inverse variance weighted,3,1.04 [0.95-1.15],0.3993915115858,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SLC16A1,Monocarboxylate transporter 1,Wald ratio,1,0.93 [0.78-1.1],0.400736883490149,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CHAD,Chondroadherin,Inverse variance weighted,3,1.02 [0.97-1.08],0.400801520363669,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SPP1,Osteopontin,Inverse variance weighted,8,0.97 [0.89-1.05],0.408168886164765,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ITGAV,Integrin alpha-V,Inverse variance weighted,5,0.97 [0.9-1.05],0.411534084799079,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,6,1.04 [0.95-1.13],0.411704790348714,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,0.97 [0.9-1.04],0.412275207299731,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GRPEL1,"GrpE protein homolog 1, mitochondrial",Wald ratio,1,1.09 [0.89-1.33],0.41928689808658,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,3,1.08 [0.9-1.29],0.420785107004457,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MEP1B,Meprin A subunit beta,Inverse variance weighted,46,1 [0.99-1.01],0.423240944185653,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SERPINA11,Serpin A11,Inverse variance weighted,31,1.01 [0.99-1.03],0.424847727273613,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,RBP2,Retinol-binding protein 2,Wald ratio,1,1.07 [0.9-1.28],0.425016294986256,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,AGRN,Agrin,Inverse variance weighted,17,0.99 [0.95-1.02],0.42578876656106,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TYMP,Thymidine phosphorylase,Inverse variance weighted,4,0.98 [0.93-1.03],0.428709867068866,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LGALS3,Galectin-3,Inverse variance weighted,25,0.99 [0.97-1.01],0.428928414279564,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,1.01 [0.98-1.05],0.433295815915825,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MMP3,Stromelysin-1,Inverse variance weighted,34,0.99 [0.97-1.01],0.438441228304699,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CTSO,Cathepsin O,Inverse variance weighted,6,0.98 [0.93-1.03],0.440604090988801,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,HSPB6,Heat shock protein beta-6,Wald ratio,1,0.9 [0.69-1.18],0.441056448593171,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LY96,Lymphocyte antigen 96,Inverse variance weighted,3,1.05 [0.93-1.17],0.443077252341827,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,29,0.99 [0.98-1.01],0.443486318620414,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,34,1.01 [0.99-1.03],0.445587672354637,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,20,0.98 [0.94-1.03],0.445830831180726,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,DPY30,Protein dpy-30 homolog,Wald ratio,1,0.91 [0.71-1.17],0.446168514496487,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MZB1,Marginal zone B- and B1-cell-specific protein,Wald ratio,1,0.89 [0.66-1.2],0.446906500387242,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MMP10,Stromelysin-2,Inverse variance weighted,22,0.99 [0.96-1.02],0.447067998631197,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD248,Endosialin,Inverse variance weighted,2,1.09 [0.87-1.35],0.451100287102346,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,WNT9A,Protein Wnt-9a,Inverse variance weighted,3,1.03 [0.95-1.12],0.453116546262691,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,DPP6,Dipeptidyl aminopeptidase-like protein 6,Inverse variance weighted,4,0.98 [0.93-1.03],0.453397460292136,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,14,1.02 [0.96-1.08],0.454746663425968,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,1.01 [0.99-1.03],0.457105303466682,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PON1,Serum paraoxonase/arylesterase 1,Inverse variance weighted,41,1 [0.98-1.01],0.457886534744154,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,8,1.02 [0.97-1.07],0.46230815392134,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MATN3,Matrilin-3,Inverse variance weighted,28,0.99 [0.97-1.02],0.464702304005268,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TXNDC15,Thioredoxin domain-containing protein 15,Inverse variance weighted,27,1.01 [0.99-1.02],0.466508140597181,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,1.04 [0.94-1.14],0.469683819647482,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TNR,Tenascin-R,Inverse variance weighted,16,1.01 [0.98-1.04],0.470377574167063,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LAYN,Layilin,Inverse variance weighted,20,0.99 [0.95-1.02],0.473401464731242,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,10,0.99 [0.95-1.03],0.475526772528404,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TFF2,Trefoil factor 2,Inverse variance weighted,5,0.98 [0.92-1.04],0.475808225406594,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,EFNA4,Ephrin-A4,Inverse variance weighted,3,0.94 [0.8-1.11],0.48252469833723,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,AREG,Amphiregulin,Inverse variance weighted,3,1.03 [0.96-1.1],0.483827834226204,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,0.93 [0.77-1.14],0.488040083790223,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,29,1.01 [0.99-1.02],0.493692994885419,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,22,0.99 [0.96-1.02],0.494449209081375,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,UMOD,Uromodulin,Inverse variance weighted,29,0.99 [0.98-1.01],0.494640867775395,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,12,0.99 [0.95-1.03],0.497307367486953,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LGALS9,Galectin-9,Inverse variance weighted,26,1.01 [0.99-1.03],0.499947311136959,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,1.03 [0.94-1.13],0.501251409159558,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SERPIND1,Heparin cofactor 2,Wald ratio,1,0.96 [0.84-1.09],0.505474758596802,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,Inverse variance weighted,20,0.99 [0.97-1.02],0.506788318109918,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,4,0.96 [0.85-1.08],0.506931333906199,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,13,1.01 [0.97-1.06],0.507361704073096,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,8,0.99 [0.96-1.02],0.509846364833159,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,2,0.94 [0.77-1.14],0.512497476197126,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,1.03 [0.95-1.11],0.514504201484161,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PRSS22,Brain-specific serine protease 4,Inverse variance weighted,7,1.01 [0.98-1.05],0.517726069903151,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CCN4,CCN family member 4,Inverse variance weighted,27,1.01 [0.99-1.03],0.518382509854496,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MET,Hepatocyte growth factor receptor,Inverse variance weighted,5,0.96 [0.84-1.09],0.519659327536926,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,Inverse variance weighted,25,0.99 [0.97-1.02],0.520743635254272,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,0.99 [0.95-1.02],0.521916970066794,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,0.96 [0.86-1.08],0.522849753041051,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,8,1.02 [0.97-1.07],0.52558929221745,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Inverse variance weighted,8,0.99 [0.96-1.02],0.526153431574331,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,27,1.01 [0.99-1.03],0.529423807640431,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,0.99 [0.95-1.02],0.531365090765354,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,KRT18,"Keratin, type I cytoskeletal 18",Wald ratio,1,0.93 [0.74-1.17],0.532036862913464,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,0.96 [0.85-1.09],0.533862463854551,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FASLG,Tumor necrosis factor ligand superfamily member 6,Wald ratio,1,0.95 [0.81-1.11],0.536925579468409,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,0.99 [0.94-1.03],0.53903562472683,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CA4,Carbonic anhydrase 4,Inverse variance weighted,12,1.01 [0.98-1.03],0.541894470167312,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,0.95 [0.8-1.13],0.54235519982264,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,0.97 [0.89-1.06],0.5476676933958,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,KLK4,Kallikrein-4,Inverse variance weighted,17,1.01 [0.98-1.03],0.547990341367557,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,17,0.99 [0.96-1.02],0.549221251881554,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,24,1.01 [0.98-1.04],0.550461365387351,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,REN,Renin,Inverse variance weighted,4,1.01 [0.97-1.07],0.556918959591742,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,KLK11,Kallikrein-11,Inverse variance weighted,6,1.01 [0.98-1.03],0.558496373043945,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PGA4,Pepsin A-4,Inverse variance weighted,2,0.96 [0.83-1.11],0.560326190456079,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,0.98 [0.93-1.04],0.562042276990886,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,1.02 [0.96-1.07],0.562187843288446,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,0.98 [0.92-1.05],0.562778339287701,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,1 [0.99-1.02],0.563453546820245,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,4,1.02 [0.96-1.08],0.564804929826348,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,0.95 [0.78-1.15],0.567931500233737,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CTSZ,Cathepsin Z,Inverse variance weighted,3,0.99 [0.95-1.03],0.571839225546269,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,HJV,Hemojuvelin,Wald ratio,1,1.02 [0.96-1.08],0.572003450144202,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,OLR1,Oxidized low-density lipoprotein receptor 1,Inverse variance weighted,2,1.06 [0.87-1.28],0.574322784232347,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CFI,Complement factor I,Inverse variance weighted,6,0.99 [0.94-1.03],0.576174331191719,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,KLK10,Kallikrein-10,Inverse variance weighted,15,0.99 [0.96-1.02],0.576875348828661,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CAPG,Macrophage-capping protein,Inverse variance weighted,33,1.01 [0.99-1.03],0.577631622204781,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,11,0.99 [0.95-1.03],0.579369035429698,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,HGF,Hepatocyte growth factor,Inverse variance weighted,2,0.97 [0.85-1.09],0.583204813449489,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CLGN,Calmegin,Inverse variance weighted,23,0.99 [0.97-1.02],0.589941082766425,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.98 [0.91-1.05],0.597555373457091,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,4,1.01 [0.96-1.07],0.597594516087799,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,4,1.03 [0.93-1.14],0.598998214877548,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CTSL,Cathepsin L1,Wald ratio,1,0.94 [0.74-1.19],0.60269026369724,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,2,0.97 [0.87-1.08],0.604358236855528,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GUSB,Beta-glucuronidase,Inverse variance weighted,4,0.98 [0.89-1.07],0.605106565220598,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,DMP1,Dentin matrix acidic phosphoprotein 1,Wald ratio,1,1.06 [0.85-1.31],0.606946113390871,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MCFD2,Multiple coagulation factor deficiency protein 2,Inverse variance weighted,2,0.98 [0.91-1.06],0.617113987714394,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LGALS4,Galectin-4,Inverse variance weighted,4,1.02 [0.94-1.1],0.624922987245162,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,11,0.98 [0.91-1.06],0.626987324562965,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,1.01 [0.98-1.04],0.627737401274677,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,1.02 [0.95-1.1],0.62785879792878,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,8,1.01 [0.97-1.05],0.629450439959053,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,NTRK3,NT-3 growth factor receptor,Inverse variance weighted,9,1.01 [0.97-1.05],0.630296175370161,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,Wald ratio,1,1.02 [0.93-1.13],0.632128990220502,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SFTPA2,Pulmonary surfactant-associated protein A2,Inverse variance weighted,19,1 [0.99-1.02],0.634947362947065,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CTSD,Cathepsin D,Inverse variance weighted,17,1.01 [0.98-1.04],0.638022144353193,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,NPTX1,Neuronal pentraxin-1,Inverse variance weighted,17,1 [0.98-1.01],0.639577879319571,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,6,0.98 [0.9-1.07],0.642223881796327,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FLT3LG,Fms-related tyrosine kinase 3 ligand,Inverse variance weighted,2,1.03 [0.91-1.16],0.643191205002886,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,5,0.98 [0.9-1.07],0.644983294313792,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LGMN,Legumain,Inverse variance weighted,12,0.99 [0.95-1.03],0.646591994834588,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PRG2,Bone marrow proteoglycan,Wald ratio,1,0.97 [0.84-1.11],0.648633013146662,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,1.01 [0.98-1.04],0.651292209208165,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,1.02 [0.94-1.1],0.662691331576366,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SEZ6L2,Seizure 6-like protein 2,Inverse variance weighted,5,0.99 [0.94-1.04],0.669604821048801,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,BPIFB1,BPI fold-containing family B member 1,Inverse variance weighted,27,1.01 [0.98-1.03],0.669776204600099,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,1 [0.99-1.02],0.671594119818033,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,DLL1,Delta-like protein 1,Inverse variance weighted,7,1.01 [0.95-1.07],0.67463608613795,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FABP5,Fatty acid-binding protein 5,Wald ratio,1,1.02 [0.94-1.1],0.676281787540911,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,1 [0.98-1.03],0.676860404591076,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,RRM2,Ribonucleoside-diphosphate reductase subunit M2,Wald ratio,1,0.96 [0.77-1.19],0.679218629925177,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,10,1.01 [0.98-1.03],0.679779399168366,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IL15,Interleukin-15,Wald ratio,1,1.24 [0.45-3.4],0.681997606183549,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MATN2,Matrilin-2,Inverse variance weighted,18,1.01 [0.97-1.04],0.682713838594518,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,1.01 [0.98-1.03],0.684942025126259,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Wald ratio,1,1.03 [0.89-1.2],0.687110359002102,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SPON2,Spondin-2,Inverse variance weighted,4,1.01 [0.96-1.06],0.687540119519731,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,VAMP5,Vesicle-associated membrane protein 5,Wald ratio,1,0.95 [0.73-1.23],0.687630338931671,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,30,1 [0.98-1.02],0.688964981113011,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,1.01 [0.98-1.04],0.690925632327552,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SIGLEC1,Sialoadhesin,Inverse variance weighted,20,0.99 [0.96-1.03],0.697736151976408,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CCL3,C-C motif chemokine 3,Inverse variance weighted,9,1.01 [0.97-1.04],0.699412147351824,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,1.01 [0.97-1.04],0.699956492451167,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,7,0.99 [0.95-1.03],0.702774982668909,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,EPO,Erythropoietin,Inverse variance weighted,5,0.98 [0.86-1.11],0.703969459459703,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,0.96 [0.77-1.2],0.705650076456195,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,1.01 [0.96-1.06],0.707475652825116,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,0.99 [0.96-1.03],0.716116939796644,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,NCAN,Neurocan core protein,Inverse variance weighted,3,1.01 [0.94-1.09],0.717037840164385,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,8,1.01 [0.97-1.04],0.721662458668803,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,1 [0.98-1.03],0.724030462304633,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PALM2,Paralemmin-2,Inverse variance weighted,8,0.99 [0.95-1.04],0.734221928012187,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,Inverse variance weighted,17,1 [0.98-1.03],0.740795039362143,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,0.96 [0.77-1.2],0.741457720194017,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GGH,Gamma-glutamyl hydrolase,Inverse variance weighted,23,1 [0.98-1.02],0.749602648583505,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SCLY,Selenocysteine lyase,Inverse variance weighted,4,1.01 [0.96-1.06],0.751320918348882,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,1.01 [0.93-1.11],0.751411675944127,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,VWC2,Brorin,Inverse variance weighted,22,1.01 [0.97-1.04],0.752724224328639,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ELN,Elastin,Inverse variance weighted,2,1.02 [0.89-1.18],0.753872192950883,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,6,1.01 [0.96-1.06],0.754199780950787,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TNC,Tenascin,Inverse variance weighted,12,0.99 [0.96-1.03],0.756135881629713,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,11,1.01 [0.97-1.05],0.757314649830974,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,0.99 [0.94-1.05],0.759457946887488,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,0.99 [0.91-1.07],0.763258890815566,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MVK,Mevalonate kinase,Inverse variance weighted,2,0.98 [0.87-1.1],0.76401733089654,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LGALS1,Galectin-1,Inverse variance weighted,6,0.99 [0.95-1.04],0.76689573124433,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,NPPB,Natriuretic peptides B,Inverse variance weighted,3,1.01 [0.95-1.07],0.767610742469244,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,4,0.99 [0.91-1.07],0.767627997750404,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,Wald ratio,1,1.01 [0.97-1.04],0.768363596009854,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TCOF1,Treacle protein,Wald ratio,1,1.03 [0.83-1.28],0.770212493155656,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CREG1,Protein CREG1,Inverse variance weighted,3,0.99 [0.93-1.05],0.77036583721263,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ADM,Pro-adrenomedullin,Inverse variance weighted,2,0.97 [0.76-1.22],0.770846982295982,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,Inverse variance weighted,21,1.01 [0.97-1.04],0.77352768405512,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GM2A,Ganglioside GM2 activator,Inverse variance weighted,24,1 [0.98-1.02],0.773536259972956,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CHGA,Chromogranin-A,Inverse variance weighted,3,1.01 [0.94-1.08],0.776020463954356,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,6,1.01 [0.94-1.09],0.776457639395376,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MSLN,Mesothelin,Inverse variance weighted,25,1 [0.98-1.02],0.778641481420079,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,0.99 [0.95-1.04],0.780611660485101,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,EGLN1,Egl nine homolog 1,Inverse variance weighted,3,0.99 [0.91-1.07],0.784742578060448,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,13,1.01 [0.95-1.07],0.787378281560395,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,RNASE6,Ribonuclease K6,Inverse variance weighted,15,1 [0.98-1.03],0.793129689676386,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,6,1 [0.99-1.02],0.795291282455741,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,13,1 [0.97-1.03],0.795574011883752,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,16,1 [0.98-1.03],0.79700264055462,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,9,1 [0.97-1.04],0.804537851516437,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CLMP,CXADR-like membrane protein,Inverse variance weighted,12,1 [0.97-1.03],0.807394981744724,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,THBD,Thrombomodulin,Inverse variance weighted,5,0.99 [0.94-1.05],0.812580912439161,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,1 [0.97-1.02],0.812883545319887,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IFNL1,Interferon lambda-1,Wald ratio,1,0.97 [0.76-1.24],0.813454384271769,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FOLR2,Folate receptor beta,Inverse variance weighted,2,0.99 [0.91-1.08],0.817080383182041,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,33,1 [0.98-1.02],0.817872801217834,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CA6,Carbonic anhydrase 6,Inverse variance weighted,31,1 [0.98-1.02],0.818870515504245,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,0.98 [0.81-1.19],0.819961170069025,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,23,1 [0.96-1.03],0.822240512751574,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,1 [0.97-1.02],0.822329705882156,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,3,1.01 [0.91-1.12],0.822705278487175,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,NECTIN2,Nectin-2,Inverse variance weighted,5,0.99 [0.89-1.1],0.823962973784698,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CCL22,C-C motif chemokine 22,Inverse variance weighted,6,0.99 [0.92-1.07],0.825970116739292,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CCN1,CCN family member 1,Inverse variance weighted,2,0.97 [0.71-1.32],0.826733318537223,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,2,1.02 [0.85-1.22],0.828359021909125,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FCAR,Immunoglobulin alpha Fc receptor,Inverse variance weighted,20,1 [0.99-1.02],0.834166867776216,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,1 [0.99-1.02],0.834182382006363,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,1.01 [0.95-1.06],0.837028094017048,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CA14,Carbonic anhydrase 14,Inverse variance weighted,8,1 [0.99-1.02],0.83724821464538,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CCL7,C-C motif chemokine 7,Inverse variance weighted,3,0.98 [0.8-1.19],0.837875884113197,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CCL20,C-C motif chemokine 20,Inverse variance weighted,2,1.01 [0.89-1.15],0.837889424174632,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CTSF,Cathepsin F,Inverse variance weighted,10,1.01 [0.95-1.06],0.8403312051923,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,5,1.01 [0.96-1.06],0.842555710984893,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,14,1 [0.97-1.03],0.844667050403732,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,1 [0.96-1.04],0.845743322422021,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,1.01 [0.94-1.08],0.849499044935208,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IL7R,Interleukin-7 receptor subunit alpha,Inverse variance weighted,47,1 [0.99-1.01],0.853847399572246,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,10,1 [0.96-1.04],0.85463895627191,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,7,1 [0.97-1.04],0.856578709883263,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,C7,Complement component C7,Inverse variance weighted,38,1 [0.99-1.02],0.85938857233127,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,AMBP,Protein AMBP,Inverse variance weighted,3,0.99 [0.92-1.07],0.859924169109408,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,5,1 [0.97-1.03],0.863403294504477,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ADA2,Adenosine deaminase 2,Inverse variance weighted,8,1 [0.94-1.05],0.864532523435962,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CNTN5,Contactin-5,Inverse variance weighted,28,1 [0.97-1.02],0.866332952633511,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,KLK13,Kallikrein-13,Inverse variance weighted,11,1 [0.98-1.03],0.866772781324413,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD27,CD27 antigen,Inverse variance weighted,9,1 [0.97-1.04],0.868034248530484,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,6,1 [0.94-1.05],0.86914788942378,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,14,1 [0.97-1.02],0.870021495090575,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,10,1 [0.97-1.03],0.872308808567938,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,1 [0.97-1.03],0.874849803254581,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CA12,Carbonic anhydrase 12,Inverse variance weighted,13,1 [0.97-1.03],0.880148615614444,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,7,1 [0.95-1.06],0.880453525855809,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Wald ratio,1,1.01 [0.89-1.15],0.880518137733351,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PSAP,Prosaposin,Inverse variance weighted,5,1.01 [0.94-1.08],0.882141548834648,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,14,1 [0.94-1.06],0.882955032354432,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD46,Membrane cofactor protein,Wald ratio,1,0.99 [0.88-1.12],0.884480937786438,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,1.01 [0.9-1.13],0.885193590205623,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SEPTIN8,Septin-8,Inverse variance weighted,2,1.01 [0.87-1.18],0.888254785741512,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,1 [0.98-1.02],0.889357386955012,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MSTN,Growth/differentiation factor 8,Inverse variance weighted,2,1 [0.93-1.06],0.893682953987939,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.98 [0.69-1.38],0.89489418510879,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CCL25,C-C motif chemokine 25,Inverse variance weighted,26,1 [0.98-1.02],0.895789922264365,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,EDN1,Endothelin-1,Inverse variance weighted,3,1 [0.96-1.05],0.900865008378123,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,10,1 [0.96-1.04],0.902019926399438,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IDUA,Alpha-L-iduronidase,Inverse variance weighted,35,1 [0.98-1.02],0.903578349658393,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,1 [0.93-1.09],0.904903942212166,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CDH2,Cadherin-2,Inverse variance weighted,3,1.01 [0.9-1.12],0.90496897453775,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",Inverse variance weighted,18,1 [0.96-1.04],0.909510535510515,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ITGAM,Integrin alpha-M,Inverse variance weighted,3,0.99 [0.89-1.11],0.909938342123957,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,DPP7,Dipeptidyl peptidase 2,Inverse variance weighted,19,1 [0.99-1.02],0.910395033164564,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SLAMF8,SLAM family member 8,Inverse variance weighted,25,1 [0.99-1.01],0.913489398908962,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,0.98 [0.74-1.3],0.913791809714696,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1 [0.93-1.09],0.916953357270612,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CNTN1,Contactin-1,Inverse variance weighted,22,1 [0.97-1.03],0.919480898375322,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Wald ratio,1,1.01 [0.88-1.15],0.920671139683341,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CTSS,Cathepsin S,Inverse variance weighted,23,1 [0.98-1.03],0.921170603502147,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,OCLN,Occludin,Inverse variance weighted,2,1 [0.92-1.09],0.930443671124925,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD48,CD48 antigen,Inverse variance weighted,18,1 [0.98-1.02],0.930557851534771,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TFF3,Trefoil factor 3,Inverse variance weighted,5,1 [0.92-1.09],0.933708617368595,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,14,1 [0.97-1.03],0.934042691766671,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,VSNL1,Visinin-like protein 1,Inverse variance weighted,8,1 [0.92-1.1],0.935971895369894,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,1.01 [0.74-1.39],0.938134383276789,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,1.01 [0.79-1.3],0.940310637938653,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,21,1 [0.97-1.03],0.941182350149253,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,1 [0.96-1.04],0.941951898816338,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FBLN2,Fibulin-2,Inverse variance weighted,11,1 [0.97-1.03],0.946305768063877,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,OMG,Oligodendrocyte-myelin glycoprotein,Wald ratio,1,1 [0.87-1.15],0.947066292237735,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,3,1 [0.88-1.12],0.948499641758768,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SIAE,Sialate O-acetylesterase,Inverse variance weighted,3,1 [0.93-1.07],0.950315124291239,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,1 [0.97-1.03],0.950908056659549,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,14,1 [0.97-1.03],0.951554019140767,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PGF,Placenta growth factor,Inverse variance weighted,2,0.99 [0.72-1.37],0.951744872235003,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,Inverse variance weighted,16,1 [0.97-1.03],0.957123179876836,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LMNB2,Lamin-B2,Wald ratio,1,1.01 [0.77-1.31],0.957551766775051,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GFER,FAD-linked sulfhydryl oxidase ALR,Wald ratio,1,1 [0.87-1.15],0.957731869887376,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FAP,Prolyl endopeptidase FAP,Inverse variance weighted,4,1 [0.96-1.04],0.958953547312317,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,1 [0.98-1.02],0.959217072918,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,1 [0.97-1.03],0.961595892687017,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FOLR1,Folate receptor alpha,Inverse variance weighted,5,1 [0.93-1.08],0.964492649746979,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IL18,Interleukin-18,Inverse variance weighted,16,1 [0.93-1.08],0.965191269409544,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Inverse variance weighted,3,1 [0.9-1.11],0.965504107669363,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,1 [0.84-1.18],0.966029484753855,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,8,1 [0.97-1.03],0.966273740500543,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,1 [0.91-1.1],0.968283248839417,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,1 [0.96-1.05],0.968965691963991,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,25,1 [0.98-1.02],0.969212531074227,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,2,1 [0.85-1.18],0.974196816532224,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,1 [0.9-1.1],0.974527669311163,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1 [0.91-1.1],0.977397816305897,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD59,CD59 glycoprotein,Inverse variance weighted,4,1 [0.93-1.08],0.977936882107016,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,3,1 [0.92-1.08],0.979602367729651,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,1 [0.98-1.02],0.980627808740251,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,11,1 [0.94-1.06],0.983550260101738,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,Inverse variance weighted,16,1 [0.98-1.02],0.985594439162165,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SULT2A1,Bile salt sulfotransferase,Inverse variance weighted,4,1 [0.97-1.04],0.98583620272654,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,1 [0.93-1.08],0.986161406436947,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,1 [0.93-1.08],0.992534500623379,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,NID1,Nidogen-1,Inverse variance weighted,6,1 [0.96-1.04],0.993559022789845,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1 [0.96-1.04],0.995429988800292,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",Inverse variance weighted,27,1 [0.97-1.03],0.996687179414359,cis
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,C7,Complement component C7,Inverse variance weighted,26,1.06 [1.03-1.08],7.14219852869869e-06,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,EFNA4,Ephrin-A4,Inverse variance weighted,2,0.79 [0.7-0.9],0.000236523091269934,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IDUA,Alpha-L-iduronidase,Inverse variance weighted,18,0.89 [0.84-0.95],0.000420805813102365,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,11,0.95 [0.92-0.98],0.00105629887542001,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,Inverse variance weighted,26,1.06 [1.02-1.1],0.0011205959102445,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TCTN3,Tectonic-3,Inverse variance weighted,44,1.03 [1.01-1.04],0.00399924538127253,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MMP12,Macrophage metalloelastase,Inverse variance weighted,2,1.31 [1.09-1.57],0.00434666554313049,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,1.1 [1.03-1.18],0.00556918450415165,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,30,0.98 [0.96-0.99],0.00587140044520504,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,2,1.25 [1.06-1.47],0.00690526132296942,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,0.83 [0.73-0.95],0.0075430906010702,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CHGA,Chromogranin-A,Inverse variance weighted,5,0.9 [0.83-0.97],0.00774947900983275,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,1.07 [1.02-1.12],0.00917596046166724,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SIGLEC1,Sialoadhesin,Inverse variance weighted,16,0.94 [0.9-0.99],0.010780393151396,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,HNMT,Histamine N-methyltransferase,Inverse variance weighted,10,1.08 [1.02-1.14],0.0131325745225776,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,4,0.91 [0.84-0.98],0.0151387405463188,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,KITLG,Kit ligand,Inverse variance weighted,30,1.05 [1.01-1.09],0.0161299258435358,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CREG1,Protein CREG1,Inverse variance weighted,20,1.02 [1-1.04],0.0181608335850883,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,AGRN,Agrin,Inverse variance weighted,14,0.94 [0.89-0.99],0.0184639238668702,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,1.06 [1.01-1.12],0.0191385016862852,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MSTN,Growth/differentiation factor 8,Inverse variance weighted,11,0.92 [0.86-0.99],0.0193695869468212,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.04 [1.01-1.08],0.0228340750601954,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CNDP1,Beta-Ala-His dipeptidase,Inverse variance weighted,48,1.02 [1-1.04],0.0235532360126999,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CAPG,Macrophage-capping protein,Wald ratio,1,0.79 [0.65-0.97],0.024313019642359,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,28,0.97 [0.95-1],0.0256313181792179,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,0.88 [0.78-0.98],0.0259493668990097,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,0.91 [0.85-0.99],0.0268607792481841,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,7,0.91 [0.84-0.99],0.0286499536606484,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GUSB,Beta-glucuronidase,Inverse variance weighted,31,1.04 [1-1.08],0.0297820009147179,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FBLN2,Fibulin-2,Inverse variance weighted,6,0.86 [0.74-0.99],0.0323059431629551,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,NPPC,C-type natriuretic peptide,Inverse variance weighted,3,0.86 [0.74-0.99],0.0335481357320105,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SCGB1A1,Uteroglobin,Inverse variance weighted,38,1.04 [1-1.07],0.0349507836389733,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,0.88 [0.77-0.99],0.0352527861814726,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FCN1,Ficolin-1,Inverse variance weighted,50,1.03 [1-1.05],0.0354234702606006,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,Inverse variance weighted,5,1.12 [1.01-1.25],0.0361851716672385,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SERPING1,Plasma protease C1 inhibitor,Inverse variance weighted,21,0.93 [0.88-1],0.0378954220788642,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,22,1.05 [1-1.11],0.0401750387285542,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,9,1.06 [1-1.12],0.0406561968360857,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,BRK1,Protein BRICK1,Inverse variance weighted,10,1.31 [1.01-1.71],0.0434970021062219,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,OMD,Osteomodulin,Inverse variance weighted,15,0.95 [0.91-1],0.0435322232049358,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,NTRK3,NT-3 growth factor receptor,Inverse variance weighted,7,0.92 [0.84-1],0.0438673670879998,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,0.91 [0.83-1],0.0454039003316686,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TFF1,Trefoil factor 1,Inverse variance weighted,14,0.97 [0.94-1],0.0472775722109158,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,13,1.08 [1-1.17],0.0481092422797077,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MCFD2,Multiple coagulation factor deficiency protein 2,Inverse variance weighted,2,0.87 [0.75-1],0.0488552138672831,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,VWC2,Brorin,Inverse variance weighted,12,0.93 [0.87-1],0.0501464426031622,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,8,1.06 [1-1.12],0.0506342025145253,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,0.93 [0.86-1],0.0507395525295519,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,11,1.09 [1-1.2],0.0510341968103968,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IL17C,Interleukin-17C,Inverse variance weighted,5,1.11 [1-1.23],0.051459651574176,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PVR,Poliovirus receptor,Inverse variance weighted,3,0.82 [0.68-1],0.0518740490926238,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MFGE8,Lactadherin,Inverse variance weighted,15,1.07 [1-1.15],0.0536840157686216,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,9,1.08 [1-1.17],0.0543133583418164,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CCL22,C-C motif chemokine 22,Inverse variance weighted,8,1.1 [1-1.22],0.06070306267075,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,RETN,Resistin,Inverse variance weighted,19,0.96 [0.92-1],0.060978791608102,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,1.13 [0.99-1.3],0.063111633789402,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,4,0.88 [0.78-1.01],0.0675644931716358,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,DMP1,Dentin matrix acidic phosphoprotein 1,Inverse variance weighted,17,0.95 [0.91-1],0.0691288095355458,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CBLN4,Cerebellin-4,Inverse variance weighted,17,1.04 [1-1.08],0.0694497708839329,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PLA2G2A,"Phospholipase A2, membrane associated",Inverse variance weighted,3,0.9 [0.8-1.01],0.0712141075205421,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GFAP,Glial fibrillary acidic protein,Inverse variance weighted,14,0.95 [0.9-1],0.0721615014762648,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,7,1.1 [0.99-1.21],0.0753126733805406,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CCN3,CCN family member 3,Inverse variance weighted,17,1.04 [1-1.08],0.0763012582819179,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,Inverse variance weighted,35,0.97 [0.95-1],0.0783638221599058,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CA6,Carbonic anhydrase 6,Inverse variance weighted,20,0.95 [0.91-1.01],0.0785944260475092,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FAM3B,Protein FAM3B,Inverse variance weighted,26,1.02 [1-1.03],0.0804960883917074,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,3,0.9 [0.8-1.01],0.0822710018956229,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MMP10,Stromelysin-2,Wald ratio,1,0.79 [0.6-1.03],0.082740829627978,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,4,0.91 [0.82-1.01],0.0839022466326708,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CSTB,Cystatin-B,Inverse variance weighted,23,1.02 [1-1.04],0.0877737094473651,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,7,1.12 [0.98-1.29],0.0880892577237812,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IMMT,MICOS complex subunit MIC60,Wald ratio,1,0.85 [0.71-1.02],0.0883930992002583,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FGF5,Fibroblast growth factor 5,Inverse variance weighted,18,1.04 [0.99-1.09],0.0897483092871646,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CTSZ,Cathepsin Z,Inverse variance weighted,16,1.03 [1-1.06],0.0897823856983983,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,0.84 [0.68-1.03],0.0943681940889887,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,1.08 [0.99-1.17],0.0953207142696949,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SOD2,"Superoxide dismutase [Mn], mitochondrial",Inverse variance weighted,7,0.89 [0.78-1.02],0.0953493062219895,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SIAE,Sialate O-acetylesterase,Inverse variance weighted,6,1.12 [0.98-1.27],0.10067569125688,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,12,0.97 [0.94-1.01],0.100782724418779,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD48,CD48 antigen,Inverse variance weighted,14,0.94 [0.88-1.01],0.100913664250227,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CPM,Carboxypeptidase M,Inverse variance weighted,19,0.95 [0.89-1.01],0.100961183933992,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PENK,Proenkephalin-A,Inverse variance weighted,15,1.04 [0.99-1.09],0.104423339147883,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MME,Neprilysin,Inverse variance weighted,46,0.98 [0.95-1.01],0.105027258554536,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,28,1.04 [0.99-1.09],0.115653036507439,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,1.08 [0.98-1.18],0.120259777739262,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,HYAL1,Hyaluronidase-1,Inverse variance weighted,19,1.04 [0.99-1.09],0.120752930857498,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,0.98 [0.95-1.01],0.122144854500647,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,8,0.92 [0.83-1.02],0.123669142794399,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,24,0.97 [0.94-1.01],0.12546962494166,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,DRAXIN,Draxin,Inverse variance weighted,25,1.05 [0.99-1.11],0.132272837713762,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD83,CD83 antigen,Inverse variance weighted,14,0.94 [0.87-1.02],0.135127674789617,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,0.93 [0.85-1.02],0.135552174782188,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,REN,Renin,Inverse variance weighted,8,0.94 [0.86-1.02],0.140041198945971,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,0.97 [0.92-1.01],0.143863089886587,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MET,Hepatocyte growth factor receptor,Inverse variance weighted,21,1.05 [0.98-1.12],0.144132910302576,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TSPAN8,Tetraspanin-8,Inverse variance weighted,19,0.96 [0.91-1.01],0.146103490146903,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,6,1.21 [0.93-1.57],0.151379283049693,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,2,0.84 [0.66-1.07],0.153997051901701,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PDCD1,Programmed cell death protein 1,Inverse variance weighted,16,0.94 [0.86-1.02],0.155732522976874,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MATN3,Matrilin-3,Inverse variance weighted,4,0.95 [0.88-1.02],0.156211080994073,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,7,1.08 [0.97-1.21],0.156402961076587,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD163,Scavenger receptor cysteine-rich type 1 protein M130,Inverse variance weighted,38,1.03 [0.99-1.08],0.15908322456148,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FAM3C,Protein FAM3C,Inverse variance weighted,3,0.92 [0.82-1.03],0.159114109639456,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,0.81 [0.61-1.08],0.159118016810277,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,9,1.08 [0.97-1.21],0.160714957294254,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CCL18,C-C motif chemokine 18,Inverse variance weighted,19,0.98 [0.96-1.01],0.160768674536352,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LGALS4,Galectin-4,Inverse variance weighted,15,0.98 [0.95-1.01],0.16084209313846,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ITGB2,Integrin beta-2,Inverse variance weighted,20,0.97 [0.94-1.01],0.160854733230672,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,4,1.09 [0.96-1.24],0.162531938223401,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MMP3,Stromelysin-1,Inverse variance weighted,4,1.11 [0.96-1.28],0.162906457645487,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MSMB,Beta-microseminoprotein,Inverse variance weighted,52,1.01 [1-1.02],0.164473602942646,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,15,1.04 [0.98-1.1],0.165401586420514,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PYY,Peptide YY,Inverse variance weighted,16,0.97 [0.93-1.01],0.169915785426804,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,1.1 [0.96-1.26],0.170651020112818,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,11,1.06 [0.98-1.15],0.170708060258766,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Wald ratio,1,0.85 [0.66-1.08],0.170763869844443,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,0.96 [0.9-1.02],0.175354767594698,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,10,0.92 [0.82-1.04],0.179014789016622,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CCL17,C-C motif chemokine 17,Inverse variance weighted,27,1.02 [0.99-1.04],0.179383303610856,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SUSD2,Sushi domain-containing protein 2,Inverse variance weighted,16,0.94 [0.87-1.03],0.180368284505065,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",Wald ratio,1,1.17 [0.93-1.46],0.183840476932414,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,0.98 [0.96-1.01],0.185702403520426,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,NPTX1,Neuronal pentraxin-1,Inverse variance weighted,46,0.99 [0.97-1.01],0.189805870701111,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,29,0.97 [0.93-1.02],0.191177236693781,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,NID1,Nidogen-1,Inverse variance weighted,6,0.96 [0.91-1.02],0.193788630989329,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,17,0.95 [0.88-1.03],0.194594299113936,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FLT3LG,Fms-related tyrosine kinase 3 ligand,Inverse variance weighted,50,1.02 [0.99-1.06],0.194643483183393,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,5,1.05 [0.97-1.14],0.199102600660872,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,8,0.95 [0.87-1.03],0.199217145026398,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PON1,Serum paraoxonase/arylesterase 1,Inverse variance weighted,28,0.93 [0.83-1.04],0.200682508646309,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,9,0.96 [0.91-1.02],0.204254319254235,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,11,1.05 [0.97-1.13],0.204566586431094,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD46,Membrane cofactor protein,Inverse variance weighted,2,0.92 [0.8-1.05],0.206173915068074,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,0.98 [0.94-1.01],0.208155988849061,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,6,1.08 [0.96-1.21],0.210409526591583,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,6,0.92 [0.81-1.05],0.215095892683959,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CDH3,Cadherin-3,Inverse variance weighted,10,1.04 [0.98-1.11],0.215797144057775,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,DSC2,Desmocollin-2,Inverse variance weighted,16,0.98 [0.95-1.01],0.216861516151975,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,20,1.02 [0.99-1.06],0.21756577604685,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,16,0.95 [0.87-1.03],0.221124400604366,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MEP1B,Meprin A subunit beta,Inverse variance weighted,72,0.99 [0.98-1],0.222104689338494,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SERPINB8,Serpin B8,Inverse variance weighted,29,1.01 [1-1.02],0.22283322104753,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,1.06 [0.96-1.17],0.22492985692696,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,10,1.03 [0.98-1.09],0.22507024907119,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.12 [0.93-1.33],0.226140505513704,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,1.13 [0.92-1.39],0.226841927097996,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,29,1.03 [0.98-1.07],0.227478354695357,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,12,1.05 [0.97-1.13],0.228015517353466,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,EBI3_IL27,Interleukin-27,Inverse variance weighted,26,1.02 [0.99-1.05],0.231510384770345,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD276,CD276 antigen,Inverse variance weighted,24,0.97 [0.93-1.02],0.231555533810013,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,0.88 [0.72-1.08],0.231995269778336,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CLEC3B,Tetranectin,Inverse variance weighted,2,0.89 [0.73-1.08],0.234189539019552,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD27,CD27 antigen,Inverse variance weighted,9,0.93 [0.83-1.05],0.236916683382027,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,UMOD,Uromodulin,Inverse variance weighted,34,0.97 [0.93-1.02],0.239735082004422,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,1.08 [0.95-1.23],0.240779430173879,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,15,0.97 [0.93-1.02],0.241324302807869,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CFI,Complement factor I,Wald ratio,1,1.21 [0.88-1.67],0.241422537830743,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,POF1B,Protein POF1B,Inverse variance weighted,4,0.94 [0.86-1.04],0.241762571269344,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,NECTIN2,Nectin-2,Inverse variance weighted,3,1.11 [0.93-1.32],0.243211248764365,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GSN,Gelsolin,Inverse variance weighted,7,0.96 [0.89-1.03],0.244677288764478,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,OGN,Mimecan,Inverse variance weighted,37,0.99 [0.97-1.01],0.246650908788193,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,EGLN1,Egl nine homolog 1,Wald ratio,1,0.86 [0.67-1.11],0.247007333439967,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GAST,Gastrin,Inverse variance weighted,9,0.96 [0.91-1.03],0.253186120718267,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CNTN5,Contactin-5,Inverse variance weighted,22,1.02 [0.99-1.06],0.253733958772623,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Wald ratio,1,0.87 [0.69-1.1],0.25435529031471,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CCL28,C-C motif chemokine 28,Inverse variance weighted,30,1.02 [0.98-1.06],0.254422710135971,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CCL7,C-C motif chemokine 7,Inverse variance weighted,14,1.03 [0.98-1.08],0.255584405093911,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PI3,Elafin,Inverse variance weighted,18,0.98 [0.94-1.02],0.256433857133482,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,2,0.93 [0.83-1.05],0.258826183140533,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,0.88 [0.7-1.1],0.259056972343496,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,11,1.05 [0.97-1.13],0.261222971772529,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FAP,Prolyl endopeptidase FAP,Inverse variance weighted,9,1.05 [0.97-1.13],0.262589967232395,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,VSNL1,Visinin-like protein 1,Inverse variance weighted,9,1.02 [0.98-1.06],0.26474739266133,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SHISA5,Protein shisa-5,Inverse variance weighted,12,0.96 [0.88-1.04],0.265267660124292,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,11,0.96 [0.9-1.03],0.272079608286518,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,9,1.04 [0.97-1.11],0.272190838576495,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,1.11 [0.92-1.33],0.274928701604686,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SPON2,Spondin-2,Inverse variance weighted,3,1.08 [0.94-1.25],0.276436014520707,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,0.96 [0.89-1.03],0.276825802126127,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CCL5,C-C motif chemokine 5,Inverse variance weighted,8,1.03 [0.98-1.09],0.278817240664726,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,RAB6A,Ras-related protein Rab-6A,Inverse variance weighted,27,0.98 [0.96-1.01],0.279877696567712,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Inverse variance weighted,3,1.04 [0.97-1.12],0.290007579891098,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD7,T-cell antigen CD7,Inverse variance weighted,12,0.99 [0.97-1.01],0.291695782897839,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SLAMF8,SLAM family member 8,Inverse variance weighted,2,1.09 [0.93-1.27],0.293880924149977,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,24,0.97 [0.91-1.03],0.294741339933521,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PALM,Paralemmin-1,Inverse variance weighted,4,1.11 [0.91-1.35],0.295082791878505,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MDK,Midkine,Inverse variance weighted,14,1.04 [0.96-1.13],0.295956975880102,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ELN,Elastin,Inverse variance weighted,10,1.09 [0.93-1.27],0.297342285174484,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,APOA2,Apolipoprotein A-II,Inverse variance weighted,15,0.97 [0.92-1.02],0.298387498020526,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,2,1.07 [0.94-1.22],0.299091692979117,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,THBS2,Thrombospondin-2,Inverse variance weighted,15,0.98 [0.94-1.02],0.30003355175848,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,16,0.98 [0.94-1.02],0.301886045244963,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CLMP,CXADR-like membrane protein,Inverse variance weighted,4,0.93 [0.8-1.07],0.303670396678748,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,RSPO3,R-spondin-3,Inverse variance weighted,5,0.95 [0.87-1.05],0.309396554098281,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IL22,Interleukin-22,Inverse variance weighted,4,1.07 [0.94-1.22],0.310430644166384,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,NUCB2,Nucleobindin-2,Inverse variance weighted,2,0.92 [0.77-1.09],0.315342633827807,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,20,0.97 [0.93-1.03],0.315573757760428,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SFTPA2,Pulmonary surfactant-associated protein A2,Inverse variance weighted,27,1.01 [0.99-1.03],0.315944566510193,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,5,0.94 [0.83-1.06],0.317095378605672,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,KLK11,Kallikrein-11,Inverse variance weighted,13,1.03 [0.97-1.09],0.317267188786245,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,KLK4,Kallikrein-4,Inverse variance weighted,5,0.91 [0.77-1.09],0.317525764776337,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CCL11,Eotaxin,Inverse variance weighted,11,1.02 [0.98-1.07],0.319991435503619,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,0.95 [0.86-1.05],0.324656853994005,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,2,1.13 [0.88-1.46],0.328826259687822,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,0.98 [0.93-1.02],0.328991258323181,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,1.02 [0.98-1.05],0.33101026644623,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,1.09 [0.92-1.28],0.331049094901298,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ALCAM,CD166 antigen,Inverse variance weighted,4,0.93 [0.81-1.08],0.339478155129417,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CLGN,Calmegin,Inverse variance weighted,6,0.96 [0.88-1.04],0.340047371435756,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SCGB3A2,Secretoglobin family 3A member 2,Inverse variance weighted,27,1.02 [0.98-1.05],0.344251551472188,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,1.04 [0.96-1.13],0.344389096885922,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,1.04 [0.96-1.13],0.344914977015354,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,COLEC12,Collectin-12,Inverse variance weighted,3,0.84 [0.59-1.21],0.350587362784132,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MMP8,Neutrophil collagenase,Inverse variance weighted,10,1.04 [0.96-1.12],0.351751558971765,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LGALS9,Galectin-9,Inverse variance weighted,36,1.01 [0.99-1.03],0.355152271098792,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,0.93 [0.79-1.09],0.357265447633846,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,AREG,Amphiregulin,Inverse variance weighted,5,1.05 [0.94-1.18],0.358752838878463,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,1.11 [0.89-1.38],0.359166776923731,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD300A,CMRF35-like molecule 8,Inverse variance weighted,35,1.01 [0.99-1.03],0.36037671277524,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SERPIND1,Heparin cofactor 2,Inverse variance weighted,32,1.02 [0.98-1.07],0.3620143059489,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,0.92 [0.76-1.1],0.363077194166573,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,15,0.97 [0.9-1.04],0.363888112194026,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,Inverse variance weighted,33,0.98 [0.93-1.03],0.365783404787847,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,1.04 [0.96-1.13],0.37085080104511,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PRL,Prolactin,Inverse variance weighted,7,1.05 [0.94-1.18],0.373319292824661,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,INSL3,Insulin-like 3,Inverse variance weighted,3,1.1 [0.89-1.35],0.375314703487407,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CTSD,Cathepsin D,Inverse variance weighted,7,1.05 [0.94-1.17],0.375803177465584,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,5,1.05 [0.94-1.16],0.376207103925478,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FUOM,Fucose mutarotase,Inverse variance weighted,6,1.04 [0.95-1.13],0.38314466071908,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,6,0.96 [0.88-1.05],0.384418244386104,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GDF15,Growth/differentiation factor 15,Wald ratio,1,1.15 [0.84-1.58],0.384425453144534,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MATN2,Matrilin-2,Inverse variance weighted,28,1.01 [0.99-1.03],0.386102502272309,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,33,1.01 [0.98-1.05],0.386905511568482,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,1.01 [0.99-1.03],0.386955538495752,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CST3,Cystatin-C,Inverse variance weighted,3,1.07 [0.92-1.23],0.387330528862023,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FASLG,Tumor necrosis factor ligand superfamily member 6,Inverse variance weighted,53,0.98 [0.95-1.02],0.39095415027025,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,16,0.97 [0.92-1.03],0.394608622111545,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,1.08 [0.91-1.28],0.395925494331805,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,6,1.06 [0.92-1.23],0.396140120958609,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,5,1.05 [0.94-1.18],0.398800668663411,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PGA4,Pepsin A-4,Inverse variance weighted,7,1.06 [0.93-1.21],0.400869107186326,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SEZ6L2,Seizure 6-like protein 2,Inverse variance weighted,9,1.05 [0.94-1.16],0.40380548364189,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,STC1,Stanniocalcin-1,Inverse variance weighted,9,0.98 [0.93-1.03],0.404693355330416,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LGALS3,Galectin-3,Inverse variance weighted,15,0.98 [0.93-1.03],0.406106892346332,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,4,1.12 [0.86-1.47],0.406402654888161,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,XCL1,Lymphotactin,Inverse variance weighted,15,0.97 [0.91-1.04],0.409259351133152,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ITGAV,Integrin alpha-V,Inverse variance weighted,10,1.03 [0.96-1.11],0.409511558275815,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LY96,Lymphocyte antigen 96,Inverse variance weighted,16,0.97 [0.91-1.04],0.410363139641763,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,1.01 [0.99-1.03],0.411162236209394,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,DPP10,Inactive dipeptidyl peptidase 10,Inverse variance weighted,24,1.01 [0.98-1.05],0.411531842365455,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FCAR,Immunoglobulin alpha Fc receptor,Inverse variance weighted,15,1.04 [0.95-1.13],0.411614711350491,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,DLL1,Delta-like protein 1,Inverse variance weighted,6,0.95 [0.85-1.07],0.412423267062169,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,5,1.05 [0.94-1.17],0.412683292833357,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SEMA3F,Semaphorin-3F,Inverse variance weighted,32,1.02 [0.97-1.08],0.413765192695901,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD34,Hematopoietic progenitor cell antigen CD34,Inverse variance weighted,2,1.17 [0.8-1.72],0.415160767341042,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SELENOP,Selenoprotein P,Inverse variance weighted,3,0.9 [0.69-1.17],0.418476569093492,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,10,0.97 [0.91-1.04],0.425307038923262,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,6,1.04 [0.94-1.14],0.427194247073274,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CFH,Complement factor H,Inverse variance weighted,7,1.03 [0.96-1.11],0.429977109409312,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,18,1.03 [0.96-1.09],0.431362731149477,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CCL23,C-C motif chemokine 23,Inverse variance weighted,23,1.01 [0.99-1.03],0.433705444488637,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GUCA2A,Guanylin,Inverse variance weighted,7,0.97 [0.9-1.04],0.434691298270909,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,15,1.02 [0.97-1.08],0.435484176743121,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD248,Endosialin,Inverse variance weighted,17,0.97 [0.9-1.05],0.437467457066931,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,21,0.99 [0.96-1.02],0.440448608856895,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IL15,Interleukin-15,Inverse variance weighted,35,0.98 [0.95-1.02],0.440714245679781,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,7,1.05 [0.93-1.17],0.441086643844859,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Inverse variance weighted,16,1.03 [0.96-1.1],0.441193653833486,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,HGF,Hepatocyte growth factor,Inverse variance weighted,5,0.94 [0.81-1.1],0.442652634704067,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CA14,Carbonic anhydrase 14,Inverse variance weighted,11,1.04 [0.94-1.16],0.44474612193143,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,4,0.96 [0.86-1.07],0.44536783911557,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,13,0.97 [0.91-1.04],0.445782310568385,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Inverse variance weighted,3,0.96 [0.88-1.06],0.447967851034865,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FAM3D,Protein FAM3D,Inverse variance weighted,38,1.01 [0.98-1.04],0.448554833330655,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,14,0.96 [0.87-1.06],0.44890478642053,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,25,0.98 [0.93-1.03],0.451000143676491,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,1.11 [0.85-1.44],0.4521189754159,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GPKOW,G-patch domain and KOW motifs-containing protein,Inverse variance weighted,2,1.06 [0.91-1.25],0.452127005966979,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LGALS3BP,Galectin-3-binding protein,Inverse variance weighted,30,1.01 [0.98-1.04],0.454698783002365,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MSLN,Mesothelin,Inverse variance weighted,11,1.04 [0.94-1.15],0.456019253309232,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,DPY30,Protein dpy-30 homolog,Wald ratio,1,1.09 [0.87-1.35],0.463373186470855,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,13,1.03 [0.96-1.1],0.466156027427276,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,OMG,Oligodendrocyte-myelin glycoprotein,Inverse variance weighted,15,1.02 [0.97-1.07],0.46662931731626,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,RNASET2,Ribonuclease T2,Inverse variance weighted,10,1.03 [0.96-1.1],0.46873530583553,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,BPIFB1,BPI fold-containing family B member 1,Inverse variance weighted,48,1.01 [0.98-1.04],0.469598956087649,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LUZP2,Leucine zipper protein 2,Wald ratio,1,0.91 [0.69-1.18],0.470342614817494,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CCL21,C-C motif chemokine 21,Inverse variance weighted,15,1.02 [0.96-1.09],0.47080355991154,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,15,1.03 [0.96-1.1],0.472732178808449,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,11,0.97 [0.91-1.05],0.473160232326668,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CCL20,C-C motif chemokine 20,Inverse variance weighted,6,0.97 [0.88-1.06],0.476010439616182,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Inverse variance weighted,6,1.04 [0.93-1.17],0.477798957799614,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,HJV,Hemojuvelin,Inverse variance weighted,2,1.14 [0.79-1.65],0.479163074866639,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,9,1.04 [0.94-1.15],0.480910460472045,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,0.96 [0.85-1.08],0.483552780328669,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PRND,Prion-like protein doppel,Inverse variance weighted,15,0.98 [0.93-1.04],0.484458483876522,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,12,1.02 [0.97-1.07],0.485579270111599,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,19,0.98 [0.94-1.03],0.486332906386677,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,7,0.96 [0.85-1.08],0.487674784414895,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,22,1.01 [0.98-1.05],0.488206860508716,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,7,0.96 [0.84-1.08],0.489263257693986,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,8,0.86 [0.56-1.32],0.49833183591576,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,10,1.02 [0.97-1.06],0.498547129791371,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,APLP1,Amyloid-like protein 1,Inverse variance weighted,9,0.98 [0.93-1.04],0.5009464691503,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,5,0.97 [0.87-1.07],0.502961702191067,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,BCAN,Brevican core protein,Inverse variance weighted,12,1.04 [0.94-1.15],0.503402201656764,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FOLR2,Folate receptor beta,Inverse variance weighted,14,0.98 [0.91-1.04],0.507020958106885,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,14,1.02 [0.95-1.1],0.511726313467321,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,0.98 [0.91-1.05],0.51679614371397,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD59,CD59 glycoprotein,Inverse variance weighted,4,1.1 [0.83-1.44],0.517279438595914,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,Inverse variance weighted,4,1.04 [0.93-1.16],0.520522507611105,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CALCA,Calcitonin,Inverse variance weighted,13,0.98 [0.92-1.05],0.520540700583252,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,Inverse variance weighted,2,1.11 [0.81-1.53],0.522490660643153,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FSTL1,Follistatin-related protein 1,Inverse variance weighted,12,1.02 [0.95-1.1],0.529452938760633,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,Inverse variance weighted,48,0.99 [0.98-1.01],0.529862527380073,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IL18,Interleukin-18,Inverse variance weighted,26,1.01 [0.98-1.05],0.532230931861385,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,THY1,Thy-1 membrane glycoprotein,Wald ratio,1,1.09 [0.83-1.43],0.536757586574167,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PALM2,Paralemmin-2,Inverse variance weighted,9,0.98 [0.94-1.03],0.538847172617303,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SPP1,Osteopontin,Inverse variance weighted,13,1.02 [0.96-1.09],0.538962539583495,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PRSS22,Brain-specific serine protease 4,Inverse variance weighted,4,1.06 [0.89-1.26],0.539806698778036,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FOLR1,Folate receptor alpha,Inverse variance weighted,6,0.97 [0.89-1.06],0.540035502132609,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,KLK10,Kallikrein-10,Wald ratio,1,1.09 [0.82-1.45],0.540490405876555,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,6,0.96 [0.84-1.09],0.541293328216349,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,6,1.03 [0.94-1.11],0.545685417009205,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,DNER,Delta and Notch-like epidermal growth factor-related receptor,Inverse variance weighted,18,0.99 [0.94-1.03],0.547259616405819,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,0.97 [0.86-1.08],0.549925929891694,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,20,1.01 [0.97-1.05],0.555141773460994,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CCN1,CCN family member 1,Inverse variance weighted,6,1.03 [0.94-1.12],0.55752509141525,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IL19,Interleukin-19,Inverse variance weighted,10,1.01 [0.98-1.05],0.557858745267173,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,HMOX2,Heme oxygenase 2,Inverse variance weighted,3,1.03 [0.93-1.15],0.558128402868787,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ORM1,Alpha-1-acid glycoprotein 1,Inverse variance weighted,21,0.99 [0.97-1.02],0.559403417136676,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,0.99 [0.95-1.03],0.559999900533137,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CTSF,Cathepsin F,Inverse variance weighted,27,1.01 [0.98-1.05],0.560729698242283,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TNC,Tenascin,Inverse variance weighted,57,1 [0.99-1.02],0.56141360881103,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ADGRD1,Adhesion G-protein coupled receptor D1,Inverse variance weighted,15,1.02 [0.95-1.1],0.561749988548235,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,Inverse variance weighted,11,1.01 [0.97-1.06],0.562334275410489,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,19,1.02 [0.96-1.07],0.563355200812377,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SEPTIN8,Septin-8,Inverse variance weighted,4,0.96 [0.84-1.1],0.56598327099062,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,0.97 [0.86-1.09],0.568809705136478,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,0.97 [0.86-1.09],0.572248513057892,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,7,0.99 [0.96-1.03],0.573051130942468,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ITGAM,Integrin alpha-M,Inverse variance weighted,12,0.98 [0.93-1.04],0.578912708639226,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,23,0.99 [0.95-1.03],0.580239977593427,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,14,0.98 [0.93-1.04],0.582340805771822,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MMP7,Matrilysin,Wald ratio,1,1.03 [0.93-1.13],0.583124360168017,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,F9,Coagulation factor IX,Inverse variance weighted,3,1.06 [0.86-1.3],0.584251509148916,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,1.01 [0.98-1.03],0.585927355014962,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GPRC5C,G-protein coupled receptor family C group 5 member C,Inverse variance weighted,7,0.98 [0.92-1.05],0.586162047121459,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,1.04 [0.91-1.19],0.589406912328819,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LMNB2,Lamin-B2,Inverse variance weighted,8,1.03 [0.93-1.13],0.592746093541703,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,0.99 [0.93-1.04],0.592936536698733,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,Inverse variance weighted,19,0.99 [0.95-1.03],0.593348639260537,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GOLM2,Protein GOLM2,Inverse variance weighted,14,0.99 [0.94-1.04],0.597149645011641,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,8,0.99 [0.96-1.03],0.597956732718145,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PSAP,Prosaposin,Inverse variance weighted,13,0.99 [0.95-1.03],0.598484806732364,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CA4,Carbonic anhydrase 4,Inverse variance weighted,25,1.01 [0.98-1.04],0.60813944965819,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,VAMP5,Vesicle-associated membrane protein 5,Wald ratio,1,1.07 [0.83-1.37],0.609784810853359,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,0.94 [0.74-1.19],0.611940463203448,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,1.04 [0.88-1.24],0.614123242327104,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,RBP2,Retinol-binding protein 2,Inverse variance weighted,5,0.97 [0.88-1.08],0.621957537068229,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,1.03 [0.92-1.15],0.622110341868218,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,KLK13,Kallikrein-13,Inverse variance weighted,11,1.01 [0.96-1.07],0.624820882984073,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,12,1.02 [0.95-1.09],0.627064974471989,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD93,Complement component C1q receptor,Inverse variance weighted,2,0.97 [0.84-1.11],0.627781636233948,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,1.01 [0.96-1.07],0.631319098018616,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,6,0.98 [0.89-1.07],0.636240282955726,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,4,0.97 [0.87-1.09],0.638208907271485,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,13,1.01 [0.97-1.05],0.639922935810044,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,KLK8,Kallikrein-8,Inverse variance weighted,5,1.02 [0.93-1.13],0.640592125318301,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,24,1.02 [0.95-1.08],0.643771310733054,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,INHBB,Inhibin beta B chain,Inverse variance weighted,11,0.99 [0.93-1.05],0.648434396705508,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,7,0.96 [0.79-1.16],0.649271321971566,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,0.96 [0.81-1.14],0.65167900486749,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ALPP,"Alkaline phosphatase, placental type",Inverse variance weighted,21,0.99 [0.94-1.04],0.653866023830658,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,14,1.02 [0.93-1.12],0.654022122806768,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,0.94 [0.7-1.25],0.654133249324916,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,7,1.03 [0.9-1.18],0.65459467304586,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,OSM,Oncostatin-M,Inverse variance weighted,6,1.02 [0.93-1.13],0.655995493602997,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IL7R,Interleukin-7 receptor subunit alpha,Inverse variance weighted,25,0.99 [0.96-1.03],0.657068092088723,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,2,0.97 [0.85-1.11],0.657636505602973,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,22,0.98 [0.89-1.08],0.661604269979745,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,34,1 [0.99-1.02],0.661641112057424,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,1 [0.98-1.03],0.662412752789244,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,1.02 [0.94-1.11],0.663097904268885,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TCN2,Transcobalamin-2,Inverse variance weighted,24,1.01 [0.98-1.03],0.663878299480087,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TNR,Tenascin-R,Inverse variance weighted,19,0.99 [0.95-1.04],0.672536351121724,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MXRA8,Matrix remodeling-associated protein 8,Inverse variance weighted,10,0.98 [0.91-1.06],0.674197024294895,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CTSS,Cathepsin S,Inverse variance weighted,7,1.02 [0.92-1.13],0.67446797585694,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,0.98 [0.87-1.09],0.677147931657323,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IL15RA,Interleukin-15 receptor subunit alpha,Wald ratio,1,1.05 [0.82-1.35],0.677255132754569,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,0.99 [0.93-1.05],0.679471456495642,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,6,1.04 [0.87-1.24],0.680757355702871,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,1.03 [0.89-1.2],0.681753237680227,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CTSO,Cathepsin O,Inverse variance weighted,19,0.97 [0.84-1.12],0.684760421090848,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,1.03 [0.88-1.22],0.686675254720069,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SERPINF1,Pigment epithelium-derived factor,Wald ratio,1,1.06 [0.81-1.38],0.68829735929446,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TCOF1,Treacle protein,Wald ratio,1,1.05 [0.82-1.35],0.688772772755967,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PGF,Placenta growth factor,Inverse variance weighted,5,1.02 [0.93-1.11],0.688994836118595,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.97 [0.85-1.11],0.690355717924901,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LGMN,Legumain,Inverse variance weighted,22,0.99 [0.93-1.05],0.69058578689631,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,2,1.03 [0.89-1.19],0.691554642404055,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",Inverse variance weighted,4,0.97 [0.83-1.13],0.691613039682623,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,0.98 [0.87-1.1],0.693678610095319,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,19,0.99 [0.97-1.02],0.695532712945953,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,1.02 [0.92-1.13],0.698109503967336,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PRSS2,Trypsin-2,Inverse variance weighted,17,1.01 [0.95-1.07],0.699247846212847,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,0.98 [0.9-1.07],0.703389739069951,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,1.03 [0.89-1.19],0.704510943095206,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,21,1.01 [0.97-1.05],0.704754674678384,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,0.99 [0.94-1.04],0.705287972549502,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,7,1.01 [0.95-1.08],0.705392273214978,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,OLR1,Oxidized low-density lipoprotein receptor 1,Inverse variance weighted,17,0.99 [0.92-1.06],0.705907712950343,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TMPRSS11D,Transmembrane protease serine 11D,Wald ratio,1,0.96 [0.75-1.21],0.706924729832951,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,1.01 [0.97-1.05],0.712133976816715,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",Inverse variance weighted,3,0.97 [0.82-1.14],0.715579066277452,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LGALS7_LGALS7B,Galectin-7,Inverse variance weighted,15,1.02 [0.93-1.11],0.71747723825333,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,0.99 [0.91-1.06],0.717718687810494,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,0.99 [0.93-1.05],0.719556205469346,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,25,0.99 [0.93-1.05],0.721977042929485,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,NCAN,Neurocan core protein,Inverse variance weighted,19,1.01 [0.94-1.09],0.722560893259277,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,0.99 [0.92-1.06],0.723072103979292,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,AGXT,Serine--pyruvate aminotransferase,Inverse variance weighted,12,0.99 [0.93-1.05],0.726652236110478,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,1.01 [0.94-1.09],0.726776992330429,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SERPINA3,Alpha-1-antichymotrypsin,Inverse variance weighted,2,0.97 [0.82-1.14],0.729066654616565,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,3,0.96 [0.75-1.22],0.732876874215023,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FCRLB,Fc receptor-like B,Inverse variance weighted,10,1.01 [0.95-1.08],0.733147186261876,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,Inverse variance weighted,32,0.99 [0.95-1.04],0.735881442004231,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,0.99 [0.93-1.06],0.73653114527928,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,EFNA1,Ephrin-A1,Inverse variance weighted,3,1.04 [0.83-1.29],0.73925428456202,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,7,0.99 [0.93-1.05],0.739342250275047,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,35,1 [0.97-1.02],0.741021780066445,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CKB,Creatine kinase B-type,Inverse variance weighted,11,1.01 [0.95-1.08],0.74957750317152,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,10,0.99 [0.94-1.04],0.750579422808741,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TXNDC15,Thioredoxin domain-containing protein 15,Inverse variance weighted,28,1 [0.97-1.03],0.760916365405093,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LAYN,Layilin,Inverse variance weighted,3,1.02 [0.88-1.19],0.761731143610234,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,0.98 [0.83-1.14],0.764694761618705,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CCN4,CCN family member 4,Inverse variance weighted,29,1 [0.98-1.03],0.765474767347599,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,0.99 [0.92-1.07],0.767906827949407,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CCL25,C-C motif chemokine 25,Inverse variance weighted,22,0.99 [0.96-1.03],0.768332661619538,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,4,0.97 [0.81-1.16],0.769423680190506,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IGFBP3,Insulin-like growth factor-binding protein 3,Inverse variance weighted,11,0.99 [0.93-1.06],0.769749775526223,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,AGR3,Anterior gradient protein 3,Inverse variance weighted,5,1.02 [0.91-1.13],0.772771349517063,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CCL3,C-C motif chemokine 3,Inverse variance weighted,15,1 [0.97-1.03],0.7729528921253,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,13,1.01 [0.95-1.07],0.776844434192929,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,Inverse variance weighted,27,1.01 [0.96-1.06],0.778585578595511,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Inverse variance weighted,6,1.01 [0.92-1.12],0.783905437070163,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,1.07 [0.65-1.78],0.784770330124006,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,RSPO1,R-spondin-1,Inverse variance weighted,8,1.01 [0.95-1.07],0.786413467618696,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TFF2,Trefoil factor 2,Inverse variance weighted,16,0.99 [0.95-1.04],0.788815805245886,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,BSG,Basigin,Inverse variance weighted,6,1.02 [0.89-1.16],0.795582694402751,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,1 [0.97-1.02],0.800660011893183,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GLA,Alpha-galactosidase A,Inverse variance weighted,2,1.04 [0.75-1.46],0.800754886910349,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,RNASE4,Ribonuclease 4,Inverse variance weighted,2,1.03 [0.82-1.29],0.802867470231367,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,0.97 [0.74-1.26],0.803709836801343,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,0.97 [0.76-1.24],0.806931135251093,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,5,1.03 [0.82-1.28],0.808592422264149,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,1.01 [0.91-1.14],0.810097742449308,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,B2M,Beta-2-microglobulin,Inverse variance weighted,7,0.99 [0.91-1.08],0.812222481657498,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GGH,Gamma-glutamyl hydrolase,Inverse variance weighted,26,0.99 [0.95-1.04],0.814362791825196,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,0.98 [0.8-1.19],0.815376923822605,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,Inverse variance weighted,7,1.01 [0.94-1.08],0.817887635602438,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,Inverse variance weighted,34,1 [0.97-1.04],0.81800800490434,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,9,1.01 [0.93-1.1],0.819306993847305,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,NECTIN4,Nectin-4,Inverse variance weighted,4,1.01 [0.9-1.15],0.824663846147386,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SULT2A1,Bile salt sulfotransferase,Inverse variance weighted,3,0.97 [0.73-1.28],0.825191369200742,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.96 [0.66-1.39],0.825627524154834,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,1.03 [0.78-1.36],0.82607383460295,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,0.97 [0.75-1.27],0.830124901588583,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,11,1.01 [0.92-1.11],0.830772924029948,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,1.01 [0.93-1.1],0.833185205279996,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CTSL,Cathepsin L1,Inverse variance weighted,29,1 [0.96-1.05],0.833436072760425,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,THBD,Thrombomodulin,Inverse variance weighted,11,1 [0.96-1.04],0.833679717122129,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,DPP6,Dipeptidyl aminopeptidase-like protein 6,Inverse variance weighted,10,1.01 [0.94-1.08],0.835302630039262,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,OCLN,Occludin,Inverse variance weighted,2,0.98 [0.83-1.17],0.837526831717205,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CA12,Carbonic anhydrase 12,Inverse variance weighted,9,1.01 [0.93-1.1],0.841449288594287,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,1.01 [0.92-1.11],0.843399040718513,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PRG2,Bone marrow proteoglycan,Inverse variance weighted,39,1 [0.97-1.02],0.843722746123915,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,Inverse variance weighted,6,1.01 [0.93-1.09],0.843926898775945,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SLC16A1,Monocarboxylate transporter 1,Inverse variance weighted,6,0.99 [0.89-1.1],0.845821689530987,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,0.99 [0.86-1.13],0.846009694547731,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,DPP7,Dipeptidyl peptidase 2,Inverse variance weighted,15,1 [0.98-1.02],0.848927552466202,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,Inverse variance weighted,4,1.01 [0.9-1.13],0.849914422735417,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,EGFR,Epidermal growth factor receptor,Inverse variance weighted,8,0.99 [0.91-1.08],0.850443812906924,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LMOD1,Leiomodin-1,Inverse variance weighted,6,1 [0.96-1.06],0.852080893310807,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SCLY,Selenocysteine lyase,Inverse variance weighted,4,1.01 [0.89-1.15],0.852459585308138,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Inverse variance weighted,3,1.02 [0.79-1.33],0.853094240266641,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,1 [0.96-1.05],0.86461159170911,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,EPO,Erythropoietin,Inverse variance weighted,11,1.01 [0.95-1.06],0.865069563694542,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,19,1 [0.96-1.05],0.867750782237206,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,6,1.01 [0.92-1.11],0.868039960734813,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IFNL1,Interferon lambda-1,Inverse variance weighted,8,1.01 [0.92-1.11],0.86853023686837,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1 [0.98-1.02],0.874490965918743,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IL6,Interleukin-6,Inverse variance weighted,6,1 [0.94-1.05],0.87552144585266,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,0.99 [0.89-1.1],0.876481104671216,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,0.99 [0.9-1.1],0.877931026201877,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PTN,Pleiotrophin,Inverse variance weighted,3,1.02 [0.82-1.26],0.880881487946071,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PRSS8,Prostasin,Inverse variance weighted,14,1 [0.94-1.07],0.884349673652514,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,1.01 [0.87-1.17],0.88536168621946,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,DEFB4A_DEFB4B,Beta-defensin 4A,Inverse variance weighted,7,1.01 [0.92-1.11],0.88718216225876,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,0.97 [0.62-1.51],0.89009123927559,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,27,1 [0.94-1.07],0.891485118397288,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SPON1,Spondin-1,Inverse variance weighted,4,1.01 [0.9-1.12],0.892526360551928,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD302,CD302 antigen,Inverse variance weighted,11,1 [0.94-1.05],0.892995762286297,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,17,1 [0.93-1.06],0.895133502845991,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MVK,Mevalonate kinase,Wald ratio,1,0.96 [0.56-1.66],0.895138952833837,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,Inverse variance weighted,14,1.01 [0.92-1.1],0.895193095212441,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,9,1 [0.94-1.08],0.895564454050877,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,1.01 [0.87-1.17],0.901882831499163,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,1 [0.98-1.02],0.902512054355009,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1.03 [0.6-1.78],0.902844097587119,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,Inverse variance weighted,20,1 [0.96-1.04],0.905907479087712,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CHAD,Chondroadherin,Inverse variance weighted,15,1 [0.97-1.04],0.90710938374655,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,0.98 [0.72-1.34],0.91157447903663,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GKN1,Gastrokine-1,Inverse variance weighted,3,0.99 [0.89-1.11],0.913294181584288,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1 [0.97-1.04],0.914077768364209,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,1 [0.93-1.09],0.91419895518394,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1 [0.93-1.09],0.916953357270612,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,12,1 [0.94-1.07],0.91733878570506,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SERPINA11,Serpin A11,Inverse variance weighted,14,1.01 [0.9-1.12],0.918694855751897,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,WNT9A,Protein Wnt-9a,Wald ratio,1,0.98 [0.73-1.33],0.921787947149665,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,2,1.01 [0.85-1.19],0.92484017415952,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ITGA11,Integrin alpha-11,Inverse variance weighted,7,1 [0.92-1.07],0.928124441139713,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,KRT18,"Keratin, type I cytoskeletal 18",Inverse variance weighted,7,1 [0.91-1.11],0.931901323813813,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CDH2,Cadherin-2,Inverse variance weighted,21,1 [0.95-1.05],0.932690366332802,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ADA2,Adenosine deaminase 2,Inverse variance weighted,10,1.01 [0.88-1.16],0.934766989990252,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,1 [0.92-1.08],0.94118782582313,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,1 [0.94-1.07],0.941762457354813,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,1 [0.94-1.05],0.942073273804431,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,1 [0.9-1.13],0.943481666232008,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,7,1 [0.9-1.1],0.943589014732038,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CCL16,C-C motif chemokine 16,Inverse variance weighted,26,1 [0.98-1.02],0.949701372523469,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,1.01 [0.84-1.2],0.952960933900784,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,2,1.01 [0.73-1.4],0.953116713570763,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,4,1 [0.91-1.11],0.95988721855425,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,6,1 [0.85-1.19],0.967537541613753,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,10,1 [0.92-1.09],0.9722882488064,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",Inverse variance weighted,2,1.01 [0.71-1.42],0.973662762026571,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,AMBP,Protein AMBP,Inverse variance weighted,5,1 [0.93-1.07],0.976114380030421,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,TFF3,Trefoil factor 3,Inverse variance weighted,10,1 [0.94-1.06],0.980040240615988,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,1 [0.84-1.2],0.980923058920005,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,1 [0.91-1.1],0.985076440059087,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,CNTN1,Contactin-1,Inverse variance weighted,25,1 [0.95-1.05],0.985578391677359,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,RNASE6,Ribonuclease K6,Inverse variance weighted,4,1 [0.87-1.15],0.985586665014641,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,1 [0.93-1.08],0.989032983547998,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,COL9A1,Collagen alpha-1(IX) chain,Inverse variance weighted,7,1 [0.93-1.08],0.993331198413901,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,18,1 [0.96-1.05],0.995713498350624,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,GRN,Progranulin,Inverse variance weighted,46,1 [0.98-1.02],0.998735057353071,trans
Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,SIT1,Signaling threshold-regulating transmembrane adapter 1,Inverse variance weighted,7,1 [0.92-1.08],0.999347760136254,trans
